Akhil Ravi

Chief Executive Officer at Aurigene Pharmaceutical Services Limited

Akhil Ravi, Chief Executive Officer at Aurigene Pharmaceutical Services Limited

Akhil Ravi is the Chief Executive Officer of Aurigene Pharmaceutical Services Limited, a subsidiary of Dr. Reddy's Laboratories that provides contract research, development and manufacturing services.1 2 He has over 15 years of experience in the pharmaceutical industry, having previously held leadership roles at Dr. Reddy's Laboratories and McKinsey & Company.1

Career Highlights

Chief Executive Officer at Aurigene Pharmaceutical Services Limited (February 2022 - Present)1
Plant Head at Dr. Reddy's Laboratories (October 2021 - January 2022)1
Europe Sales Head, API at Dr. Reddy's Laboratories (September 2018 - September 2021)1
Head of Strategy, API at Dr. Reddy's Laboratories (March 2018 - September 2021)1
Engagement Manager at McKinsey & Company (January 2017 - February 2018)1

Education

Indian School of Business, Master of Business Administration (MBA) in Entrepreneurship/Entrepreneurial Studies (2012 - 2013)1
Indian Institute of Technology, Bombay, B.Tech in Chemical Engineering (2003 - 2007)1

Akhil Ravi is a graduate of IIT Bombay and the Indian School of Business. He has led strategic initiatives for the API division at Dr. Reddy's and was a management consultant at McKinsey & Company before joining Aurigene.1

In April 2024, Akhil announced that Aurigene and Nestlé are forming a joint venture to market innovative nutraceutical products.4 He is working to expand Aurigene's biologics CDMO capabilities through organic growth and collaborations.2 3

Experience

Chief Executive Officer at Aurigene Pharmaceutical Services Limited since February 2022

Plant Head at Dr. Reddy's Laboratories, Engagement Manager and Junior Associate at McKinsey & Company, Co-founder at IndiaKhelo, Assistant Manager at ITC Limited